Pro-Dex, Inc. Announces Contract Extension With Largest Customer

Pro-Dex (NasdaqCM: PDEX) announced a contract amendment with its largest customer executed on December 17, 2025 that extends an agreement scheduled to terminate on December 31, 2025 through December 31, 2028.

Rhea-AI Summary

Pro-Dex (NasdaqCM: PDEX) announced a contract amendment with its largest customer executed on December 17, 2025 that extends an agreement scheduled to terminate on December 31, 2025 through December 31, 2028. The amendment includes minimum purchase volumes for 2026 and 2027, and continues a commercial relationship that will total more than fifteen years.

The company makes autoclavable, battery-powered and electric surgical drivers and shavers, licensed torque-limiting software, and sells rotary air motors (described as a de minimis portion of revenue). Management framed the amendment as positioning Pro-Dex for continued revenue growth.

Positive

• Contract extended through December 31, 2028
• Minimum purchase volumes specified for 2026 and 2027
• Over 15 years of ongoing customer relationship secured

Negative

• None.

Argus Dec 22 session

+10.34% close to close Open Argus

Details

News Market Reaction – PDEX

On Dec 22, the first trading day after this news, PDEX closed 10.34% above the previous close.

Data tracked by StockTitan Argus for the Dec 22 session.

Market Context

On Dec 22, the first trading day after this news, the stock closed 10.3% above the previous close. A...

Analysis

On Dec 22, the first trading day after this news, the stock closed 10.3% above the previous close. A strong positive reaction aligns with the strategic nature of this announcement, as Pro-Dex secured its largest customer through December 31, 2028 with specified minimum purchase years in 2026 and 2027. Historical data showed prior positive fundamentals sometimes met with negative next-day moves, so a sharp gain would have marked a break from that pattern. Investors would have weighed the multi-year visibility against previously observed post-news volatility.

Key Figures

Contract extension term: 3 years Original contract end: December 31, 2025 New contract end: December 31, 2028 +2 more

Contract extension term

3 years

Amendment with largest customer executed on December 17, 2025

Original contract end

December 31, 2025

Previous termination date before amendment

New contract end

December 31, 2028

Extended term with largest customer

Minimum purchase years

2026 and 2027

Contract includes minimum purchase volumes for these calendar years

Collaboration duration

More than fifteen years

Total relationship length with largest customer after amendment

Historical Context

3 past events · Latest: Oct 30

3 events

1. Oct 30

   Earnings release

   24h Move

   -0.3%

   Q1 FY26 net sales up 24% with strong income and investment gains.

2. Oct 16

   Corporate clarification

   24h Move

   -4.8%

   Clarified no affiliation with crypto entity using the PDEX symbol.

3. Sep 04

   Earnings release

   24h Move

   -16.5%

   FY25 sales and net income up sharply with large backlog reported.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

autoclavable, orthopedic, thoracic, torque-limiting software, +1 more

5 terms

autoclavable medical

"design, development, and manufacture of autoclavable, battery-powered and electric"

Able to withstand repeated sterilization in an autoclave, meaning the item can tolerate high-temperature, high-pressure steam without melting, deforming or losing function. For investors, an “autoclavable” label signals that medical devices, lab tools or packaging meet hygiene and regulatory needs, can lower replacement costs, and may be preferred by hospitals and labs—making products more marketable and durable in healthcare and scientific markets.

orthopedic medical

"used primarily in the orthopedic, thoracic, and maxocranial facial markets"

Relating to the prevention, diagnosis and treatment of injuries and disorders of the bones, joints, muscles, tendons and ligaments; commonly associated with surgeries, implants (like joint replacements or screws), braces and rehabilitation. Investors pay attention because orthopedic activity drives demand for medical devices, hospital services and rehab products—like how road repairs create business for construction firms—so changes in procedure volumes, new implant approvals or shifts in care settings can affect revenues and growth prospects for companies in this sector.

thoracic medical

"used primarily in the orthopedic, thoracic, and maxocranial facial markets"

Relating to the chest area of the body, including the lungs, heart-adjacent structures, ribs and the passageways between them. Investors encounter 'thoracic' in descriptions of medical devices, surgeries or diseases affecting the chest; it matters because advances, approvals or setbacks in thoracic care can change demand for treatments, influence clinical trial results and affect revenue for medical companies and hospitals, much like work on a home's central utility room impacts the whole house.

torque-limiting software technical

"We have patented adoptive torque-limiting software and proprietary sealing solutions"

Software that monitors and restricts the twisting force (torque) produced by a motor or tool to predetermined safe or performance limits. Like a speed governor on a car, it prevents components or users from being damaged by excessive force, helping products meet safety rules, reduce warranty claims, and avoid liability. Investors care because it affects regulatory approval, product reliability, manufacturing costs, and brand trust, all of which influence sales and risk.

forward-looking statements regulatory

"may include 'forward-looking statements' within the context of the federal securities laws"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

IRVINE, CA / ACCESS Newswire / December 19, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced that on December 17, 2025, it executed a contract amendment with its largest customer for an additional three years. The contract, which was scheduled to terminate on December 31, 2025, has now been extended through December 31, 2028. The contract also contains minimum purchase volumes for each of the 2026 and 2027 calendar years.

"We are pleased to secure the business of our largest customer for an additional three years," said Richard L. ("Rick") Van Kirk, the Company's President and Chief Executive Officer. "This amendment will culminate in more than fifteen years of collaboration with this customer and positions us for continued revenue growth. We are committed to delivering long-term value to all of our customers, many of whom we have been serving for over a decade."

About Pro-Dex, Inc.:

Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. We have patented adoptive torque-limiting software and proprietary sealing solutions that appeal to our customers, primarily medical device distributors. Additionally, we provide engineering, quality, and regulatory consulting services to our customers. We also manufacture and sell rotary air motors to a wide range of industries; however, these motors comprise a de minimis portion of our business.For more information, visit the Company's website at www.pro-dex.com.

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.

Contact: Richard L. Van Kirk, Chief Executive Officer
(949) 769-3200

SOURCE: Pro-Dex, Inc.

View the original press release on ACCESS Newswire

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Pro-Dex (PDEX) announce on December 17, 2025 about its largest customer?

Pro-Dex executed a contract amendment on December 17, 2025 extending the agreement through December 31, 2028.

Does the Pro-Dex contract extension (PDEX) include minimum purchase commitments?

Yes. The amendment includes minimum purchase volumes for each of the 2026 and 2027 calendar years.

How long will Pro-Dex and its largest customer have worked together after the PDEX amendment?

The amendment will culminate in more than fifteen years of collaboration with that customer.

What product lines does Pro-Dex (PDEX) supply that relate to this contract extension?

Pro-Dex designs and manufactures autoclavable battery-powered and electric multi-function surgical drivers and shavers used in orthopedic, thoracic, and maxocranial facial markets.

Will the Pro-Dex (PDEX) contract extension likely affect near-term revenue visibility?

The amendment extends the contract through 2028 and sets minimum purchases for 2026–2027, which the company said positions it for continued revenue growth.

Where can investors find more information about Pro-Dex (PDEX)?

Investors can visit the company's website at www.pro-dex.com for more information.